Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FCAN
5601
DELISTED
First Trust Canada AlphaDEX Fund
FCAN
| $62K | ﹤0.01% |
2,447
-552
| -18% | -$13.4K |
2013 Q2
17 quarters
|
|
|
OREX
5602
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $62K | ﹤0.01% |
29,234
+4,121
| +16% | +$10.1K |
2013 Q2
17 quarters
|
|
5603
DELISTED
AstroNova
ALOT
| $61K | ﹤0.01% |
4,682
+618
| +15% | +$8.35K |
2013 Q4
15 quarters
|
|
5604
iPath Select MLP ETN
ATMP
$619M
| $61K | ﹤0.01% |
2,850
-1,000
| -26% | -$21.8K |
2015 Q4
7 quarters
|
|
5605
Princeton Bancorp
BPRN
$295M
| $61K | ﹤0.01% |
+1,905
| New | +$60.5K |
2017 Q3
0 quarters
|
|
5606
ProShares Ultra Technology
ROM
$1.31B
| $61K | ﹤0.01% |
6,536
-3,944
| -38% | -$35.3K |
2013 Q4
15 quarters
|
|
|
ZIV
5607
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
| $61K | ﹤0.01% |
809
+800
| +8,889% | +$58.1K |
2015 Q4
7 quarters
|
|
|
JASN
5608
DELISTED
Jason Industries, Inc.
JASN
| $61K | ﹤0.01% |
38,227
-52,732
| -58% | -$65.2K |
2014 Q3
12 quarters
|
|
|
NYH
5609
DELISTED
Eaton Vance New York Municipal Bond Fund II
NYH
| $61K | ﹤0.01% |
5,131
+1,601
| +45% | +$19.2K |
2013 Q4
15 quarters
|
|
|
STH
5610
DELISTED
SABRIENT STEALTH PRT CLAYMORE EXCH TRD FD
STH
| $61K | ﹤0.01% |
1,791
| – | – |
2013 Q4
15 quarters
|
|
5611
DELISTED
BioAmber Inc.
BIOA
| $60K | ﹤0.01% |
120,697
+107,595
| +821% | +$128K |
2013 Q4
15 quarters
|
|
5612
DELISTED
First Trust Taiwan AlphaDEX Fund
FTW
| $60K | ﹤0.01% |
1,688
-91
| -5% | -$3.37K |
2013 Q4
15 quarters
|
|
5613
Asure Software
ASUR
$207M
| $59K | ﹤0.01% |
4,740
-29,252
| -86% | -$363K |
2013 Q4
15 quarters
|
|
5614
J.W. Mays
MAYS
| $59K | ﹤0.01% |
1,653
| – | – |
2013 Q4
15 quarters
|
|
5615
Ovid Therapeutics
OVID
$428M
| $59K | ﹤0.01% |
6,905
+1,848
| +37% | +$15.4K |
2017 Q2
1 quarter
|
|
|
ZEAL
5616
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $59K | ﹤0.01% |
+3,046
| New | +$57.4K |
2017 Q3
0 quarters
|
|
|
TRPX
5617
DELISTED
Therapix Biosciences Ltd.
TRPX
| $59K | ﹤0.01% |
10,250
-1,000
| -9% | -$5.99K |
2017 Q1
2 quarters
|
|
|
FEEU
5618
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
| $59K | ﹤0.01% |
457
-1,055
| -70% | -$129K |
2015 Q4
7 quarters
|
|
5619
RiverNorth Opportunities Fund
RIV
$309M
| $58K | ﹤0.01% |
2,914
+1,881
| +182% | +$38.1K |
2016 Q3
4 quarters
|
|
5620
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.14B
| $58K | ﹤0.01% |
1,800
+600
| +50% | +$19.5K |
2013 Q2
17 quarters
|
|
5621
Vident US Bond Strategy ETF
VBND
$516M
| $58K | ﹤0.01% |
+1,156
| New | +$57.7K |
2017 Q3
0 quarters
|
|
|
CEA
5622
DELISTED
China Eastern Airlines
CEA
| $58K | ﹤0.01% |
2,396
+720
| +43% | +$19.9K |
2013 Q2
17 quarters
|
|
|
CHKR
5623
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
| $58K | ﹤0.01% |
28,040
+9,253
| +49% | +$21K |
2013 Q2
17 quarters
|
|
|
PQ
5624
DELISTED
Petroquest Energy Inc Wd
PQ
| $58K | ﹤0.01% |
25,263
+4,826
| +24% | +$9.54K |
2016 Q2
5 quarters
|
|
|
CHOC
5625
DELISTED
iPath Pure Beta Cocoa ETN
CHOC
| $58K | ﹤0.01% |
1,902
| – | – |
2015 Q4
7 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.